US Stock MarketDetailed Quotes
APLIF APPILI THERAPEUTICS INC
- 0.029400
- +0.004400+17.60%
15min DelayClose May 2 16:00 ET
3.57MMarket Cap-1013P/E (TTM)
0.029400High0.029400Low112.28KVolume0.029400Open0.025000Pre Close3.30KTurnover0.09%Turnover RatioLossP/E (Static)121.27MShares0.07550052wk High-0.50P/B3.57MFloat Cap0.01620052wk Low--Dividend TTM121.27MShs Float1.070000Historical High--Div YieldTTM0.00%Amplitude0.016200Historical Low0.029000Avg Price1Lot Size
APPILI THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 126.45%253.24K | 92.34%-237.14K | 59.01%-2.02M | 47.08%-10.1M | 71.29%-1.11M | 83.71%-957.3K | -20.01%-3.09M | 27.00%-4.94M | -66.64%-19.08M | 10.90%-3.86M |
| Net income from continuing operations | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M | 85.34%-1.64M | 68.45%-2.32M | -75.34%-25.12M | 33.13%-3.33M |
| Operating gains losses | -103.77%-102.51K | -61.69%95.99K | -190.32%-142.89K | 801.86%403.29K | 140.86%44.85K | -221.39%-50.31K | 2,504.40%250.54K | 12,638.08%158.21K | -353.14%-57.46K | -2,533.86%-109.77K |
| Depreciation and amortization | 119.33%3.39K | 122.64%3.44K | 122.21%3.44K | -50.44%6.27K | -52.29%1.62K | -46.95%1.55K | -51.87%1.55K | -50.21%1.55K | -14.78%12.64K | -9.97%3.4K |
| Other non cash items | 29.27%158.07K | -226.20%-138.14K | 120.36%381.47K | -29.51%1.1M | -26.76%843.04K | -49.67%122.28K | -131.09%-42.35K | 598.54%173.11K | 6,653.99%1.55M | 10,878.98%1.15M |
| Change In working capital | -76.34%328.92K | 141.49%761.87K | 71.91%-864.66K | -230.10%-3.24M | 114.75%288.41K | 138.78%1.39M | -123.29%-1.84M | -2,258.47%-3.08M | 51.46%2.49M | -527.91%-1.95M |
| -Change in receivables | -17.39%199.01K | 680.77%22.78K | -420.47%-902.67K | 228.83%970.29K | 41.28%444.8K | 221.02%240.91K | -99.65%2.92K | 143.03%281.67K | 121.49%295.08K | 132.66%314.84K |
| -Change in prepaid assets | -107.00%-5.46K | -36.58%61.39K | 80.01%-54.67K | -117.78%-47.55K | -5.84%51.07K | -16.32%78.07K | 152.89%96.8K | -190.28%-273.49K | 214.76%267.47K | 239.00%54.24K |
| -Change in payables and accrued expense | -87.36%135.38K | 135.00%677.7K | 103.00%92.67K | -316.08%-4.16M | 91.07%-207.46K | 148.39%1.07M | -132.44%-1.94M | -724.36%-3.09M | -40.02%1.92M | -265.40%-2.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 126.45%253.24K | 92.34%-237.14K | 59.01%-2.02M | 47.08%-10.1M | 71.29%-1.11M | 83.71%-957.3K | -20.01%-3.09M | 27.00%-4.94M | -66.64%-19.08M | 10.90%-3.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -897.77%-29.72K | -100.06%-3.18K | -923.06%-6.68K | 0 | -102.53%-225 | -99.93%3.73K | 201.38%5.06M | -97.71%811 |
| Net PPE purchase and sale | --0 | --0 | -897.77%-29.72K | ---3.18K | -923.06%-6.68K | --0 | 79.43%-225 | --3.73K | --0 | 163.51%811 |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 201.55%5.06M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | -897.77%-29.72K | -100.06%-3.18K | -923.06%-6.68K | --0 | -102.53%-225 | -99.93%3.73K | 201.38%5.06M | -97.71%811 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -8.63%-45.88K | 364.29%111.72K | -97.20%107.58K | -38.23%5.91M | 103.32%2.16M | -100.80%-42.24K | -101.30%-42.27K | 13,551.71%3.84M | -43.80%9.56M | 702.67%1.06M |
| Net issuance payments of debt | -29.49%-28.1K | 717.22%130.22K | 718.41%126.78K | -36.95%2.41M | 78.87%2.48M | 97.87%-21.7K | -100.61%-21.1K | -12.99%-20.5K | 21,843.90%3.83M | --1.39M |
| Net common stock issuance | --0 | --0 | --0 | -39.86%3.21M | --0 | --0 | --0 | --3.21M | -59.11%5.34M | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -24.36%1.29M | --0 | --0 | --0 | 2,840.72%1.29M | -68.48%1.7M | --0 |
| Net other financing activities | ---- | ---- | ---- | 24.10%-922.61K | 0.38%-300.65K | --0 | --0 | -1,973.18%-621.96K | 13.18%-1.22M | ---301.81K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -8.63%-45.88K | 364.29%111.72K | -97.20%107.58K | -38.23%5.91M | 103.32%2.16M | -100.80%-42.24K | -101.30%-42.27K | 13,551.71%3.84M | -43.80%9.56M | 702.67%1.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -83.69%395.62K | -90.63%520.59K | -63.00%2.47M | -39.76%6.66M | -84.77%1.43M | -75.71%2.43M | -40.30%5.55M | -39.76%6.66M | 5.26%11.06M | -38.49%9.37M |
| Current changes in cash | 120.75%207.36K | 96.00%-125.42K | -77.26%-1.95M | 5.89%-4.19M | 137.17%1.04M | -70.00%-999.54K | -551.50%-3.14M | 37.62%-1.1M | -875.08%-4.45M | 32.79%-2.8M |
| Effect of exchange rate changes | -106.68%-96 | -94.53%448 | 105.12%690 | -111.23%-6.38K | -102.69%-2.53K | 105.90%1.44K | 165.34%8.19K | -2,516.12%-13.47K | 364.79%56.82K | 2,153.49%94.21K |
| End cash Position | -57.76%602.88K | -83.69%395.62K | -90.63%520.59K | -63.00%2.47M | -63.00%2.47M | -84.77%1.43M | -75.71%2.43M | -40.30%5.55M | -39.76%6.66M | -39.76%6.66M |
| Free cash flow | 126.45%253.24K | 92.34%-237.14K | 58.41%-2.05M | 47.06%-10.1M | 71.20%-1.11M | 83.71%-957.3K | -19.96%-3.09M | 27.00%-4.94M | -66.52%-19.08M | 10.95%-3.86M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg